How Is The Flow Diverters Market Size Forecasted To Progress From 2026 To 2030?
The flow diverters market size has grown rapidly in recent years. It will grow from $0.55 billion in 2025 to $0.62 billion in 2026 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to limited availability of specialized flow diverters, reliance on traditional surgical clipping and coiling, growing awareness of intracranial aneurysm treatment, increasing hospital and clinic neurovascular capabilities, adoption of early generation nitinol stents.
The flow diverters market size is expected to see rapid growth in the next few years. It will grow to $0.95 billion in 2030 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to development of next-generation flow diverters with enhanced flexibility, rising demand for minimally invasive neurovascular procedures, growing investment in hospital endovascular infrastructure, increasing regulatory approvals for new devices, integration of imaging and AI-assisted deployment technologies. Major trends in the forecast period include rising adoption of minimally invasive neurovascular procedures, increasing use of flow diverters in complex aneurysms, development of advanced nitinol and cobalt-chromium devices, expansion of endovascular treatment centers, focus on reducing procedure complications and enhancing patient safety.
Claim Your Free Report Sample Today:
What Significant Demand Drivers Are Anticipated To Influence The Flow Diverters Market Over The Coming Years?
The rising prevalence of aneurysms is expected to propel the growth of the flow diverters market going forward. Aneurysms refer to abnormal bulges or ballooning in the wall of a blood vessel, typically caused by weakening of the vessel wall. The increase in prevalence of aneurysms is driven by a rising aging population and improved diagnostic technologies, as they lead to higher detection rates and greater awareness, thereby increasing the number of diagnosed cases. Flow diverters help address the rising prevalence of aneurysms by redirecting blood flow away from the weakened vessel area, promoting healing, reducing the risk of rupture, and offering a minimally invasive alternative to traditional surgical treatments. For instance, in November 2025, according to the PubMed, a U.S.-based biomedical literature database or search engine, it was reported that about 3% of adults have an unruptured intracranial aneurysm, and this prevalence can increase to 10% in high-risk groups. Therefore, the rising prevalence of aneurysms is driving the growth of the flow diverters market.
What Segment Divisions Provide The Most Valuable Insights Into The Flow Diverters Market?
The flow diverters market covered in this report is segmented –
1) By Type: Pipeline Embolization Device, Silk Flow Diverter, Surpass Flow Diverter, Flow Redirection Endoluminal Device, Other Types
2) By Material: Nitinol, Cobalt-Chromium Alloy, Stainless Steel, Other Materials
3) By Application: Intracranial Aneurysms, Arteriovenous Malformations, Complex Wide-Neck Aneurysms, Other Applications
4) By End-User: Hospital And Clinics, Ambulatory Surgical Centre
Subsegments:
1) By Pipeline Embolization Device: Classic Pipeline Embolization Device, Pipeline Flex Embolization Device, Pipeline Shield Technology
2) By Silk Flow Diverter: Silk+ Flow Diverter, Silk Vista Baby
3) By Surpass Flow Diverter: Surpass Streamline, Surpass Evolve
4) By Flow Redirection Endoluminal Device: FRED Jr., FRED X
5) By Other Types: DERIVO Embolization Device, p64 Flow Modulation Device, Tubridge Flow Diverter
What New Trends Are Beginning To Take Shape Within The Flow Diverters Market?
Major companies operating in the flow diverters market are focusing on advancements in material science, such as polymer-based neurovascular stents, to enhance device performance, improve biocompatibility, promote natural vessel healing, and reduce the need for long-term blood-thinning medication. A polymer-based neurovascular stent is a medical implant designed to support and maintain the patency of blood vessels in the brain (neurovasculature), particularly in the treatment of conditions such as aneurysms, stenosis, or vascular malformations. For instance, in June 2023, Fluid Biomed, a Canada-based medical device start-up, announced the world’s first implantation of a polymer-based neurovascular stent in human patients. This innovative device, known as the ReSolv stent, is specifically designed to treat brain aneurysms. Unlike traditional hybrid polymer-metal stents, the ReSolv stent is entirely polymer-based and is engineered to gradually dissolve as the blood vessel heals. This unique design has the potential to minimize the need for long-term blood-thinning medication while supporting the natural healing process of the vessel.
Who Are The Key Companies Actively Operating Within The Flow Diverters Market?
Major companies operating in the flow diverters market are Johnson & Johnson, Medtronic plc, Stryker Corporation, Terumo Corporation, MicroPort Scientific Corporation, Penumbra Inc., Phenox GmbH, Sino Medical Sciences Technology Inc., Balt Extrusion S.A.S., Sequent Medical Inc., Wallaby Medical Ltd., Zylox Tonbridge Medical Technology Co. Ltd., Acandis GmbH & Co. KG, Fluid Biomed Inc., Oxford Endovascular Ltd., EndoStream Medical Ltd., Rapid Medical Ltd., Cerus Endovascular Ltd., NeuroVasc Technologies Inc., Shape Memory Medical Inc., Vesalio LLC
Get Your In-Depth Flow Diverters Market Report Now:
Which Regions Are Projected To Advance The Fastest Over The Forecast Horizon In The Flow Diverters Market?
North America was the largest region in the flow diverters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the flow diverters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: Market Research Reports
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment